Tentative guidelines for using clinical and economic evaluations revisited.
作者信息
Laupacis A, Feeny D, Detsky A S, Tugwell P X
机构信息
Department of Medicine, University of Ottawa, Ont.
出版信息
CMAJ. 1993 Mar 15;148(6):927-9.
Abstract
摘要
相似文献
1
Tentative guidelines for using clinical and economic evaluations revisited.再探临床与经济评估使用的暂行指南。
CMAJ. 1993 Mar 15;148(6):927-9.
2
Technology assessment and cost-effectiveness analysis: misguided guidelines?技术评估与成本效益分析：误导性指南？
CMAJ. 1993 Mar 15;148(6):921-4.
3
Basic concepts and fundamental issues in technology assessment.技术评估中的基本概念与根本问题。
Intensive Care Med. 1993;19(2):117-21. doi: 10.1007/BF01708374.
4
5
6
EUR-ASSESS Project Subgroup report on Methodology. Methodological guidance for the conduct of health technology assessment.欧洲评估项目方法学分组报告。卫生技术评估实施的方法学指南。
Int J Technol Assess Health Care. 1997 Spring;13(2):186-219. doi: 10.1017/s0266462300010369.
7
The importance of subjective values to medical technology assessment and health policy.主观价值对医学技术评估和卫生政策的重要性。
J Invasive Cardiol. 1993 Jan-Feb;5(1):17-22.
8
Developing Guidance on Ethics for Patient Groups Collecting and Reporting Patient Information for Health Technology Assessments.为卫生技术评估收集和报告患者信息的患者群体制定伦理指南。
Patient. 2016 Feb;9(1):1-4. doi: 10.1007/s40271-015-0143-y.
9
Magnetic resonance imaging: in need of assessment.磁共振成像：需要评估。
Dimens Health Serv. 1991 Mar;68(2):24-6.
10
Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria.经济评估方法学质量评估标准清单：健康经济标准共识
Int J Technol Assess Health Care. 2005 Spring;21(2):240-5.
引用本文的文献
1
Cost-utility and cost-benefit analyses of school-based obesity prevention program.基于学校的肥胖预防计划的成本-效用和成本效益分析。
BMC Public Health. 2020 Oct 23;20(1):1608. doi: 10.1186/s12889-020-09718-x.
2
Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer.多基因表达谱分析检测指导浸润性早期乳腺癌女性辅助治疗决策的成本效果分析。
Pharmacogenomics J. 2020 Feb;20(1):27-46. doi: 10.1038/s41397-019-0089-x. Epub 2019 May 27.
3
Optimizing HIV pre-exposure prophylaxis implementation among men who have sex with men in a large urban centre: a dynamic modelling study.在一个大型城市中心优化男男性行为者中艾滋病病毒暴露前预防措施的实施：一项动态建模研究
J Int AIDS Soc. 2016 Sep 23;19(1):20791. doi: 10.7448/IAS.19.1.20791. eCollection 2016.
4
Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary.使用基因表达谱检测辅助识别原发灶不明癌症患者的原发肿瘤的成本效益
Pharmacogenomics J. 2017 Jun;17(3):286-300. doi: 10.1038/tpj.2015.94. Epub 2016 Mar 29.
5
Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.骨折联络服务的成本效益——服务提供6年后的实际评估
Osteoporos Int. 2016 Jan;27(1):231-40. doi: 10.1007/s00198-015-3280-1. Epub 2015 Aug 15.
6
Economic impact of minimally invasive lumbar surgery.微创腰椎手术的经济影响。
World J Orthop. 2015 Mar 18;6(2):190-201. doi: 10.5312/wjo.v6.i2.190.
7
Health Economics Information in Wound Care: The Elephant in the Room.伤口护理中的卫生经济学信息：房间里的大象（指被忽视的重要问题）
Adv Wound Care (New Rochelle). 2013 Dec;2(10):563-570. doi: 10.1089/wound.2013.0479.
8
Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in Canada.拉帕替尼联合来曲唑治疗加拿大人表皮生长因子受体 2 阳性、激素受体阳性转移性乳腺癌的成本效果分析。
Curr Oncol. 2013 Oct;20(5):e371-87. doi: 10.3747/co.20.1394.
9
Grade 2 spondylolisthesis at L4-5 treated by XLIF: safety and midterm results in the "worst case scenario".XLIF治疗L4-5节段二度腰椎滑脱：“最坏情况”下的安全性及中期结果
ScientificWorldJournal. 2012;2012:356712. doi: 10.1100/2012/356712. Epub 2012 Oct 17.
10
Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer.21 基因复发评分检测与加拿大临床实践在早期雌激素或孕激素受体阳性、腋窝淋巴结阴性乳腺癌女性中的成本效益比较。
BMC Cancer. 2012 Oct 2;12:447. doi: 10.1186/1471-2407-12-447.
本文引用的文献
1
Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.存在外部性时基于成本效用分析进行医疗保健资源分配的影响。
J Health Econ. 1992 Oct;11(3):259-77. doi: 10.1016/0167-6296(92)90003-j.
2
What do patients value? Willingness to pay for ultrasound in normal pregnancy.患者看重什么？正常妊娠中超声检查的支付意愿。
Med Care. 1985 Jul;23(7):881-93.
3
Utility approach to measuring health-related quality of life.测量健康相关生活质量的效用方法。
J Chronic Dis. 1987;40(6):593-603. doi: 10.1016/0021-9681(87)90019-1.
4
Methodology for measuring health-state preferences--II: Scaling methods.健康状态偏好测量方法——II：标度法。
J Clin Epidemiol. 1989;42(5):459-71. doi: 10.1016/0895-4356(89)90136-4.
5
A clinician's guide to cost-effectiveness analysis.临床医生成本效益分析指南。
Ann Intern Med. 1990 Jul 15;113(2):147-54. doi: 10.7326/0003-4819-113-2-147.
6
Risk reduction from low osmolality contrast media. What do patients think it is worth?低渗性造影剂降低风险。患者认为这有多大价值？
Med Care. 1990 Apr;28(4):324-37. doi: 10.1097/00005650-199004000-00004.
7
Measuring the adverse effects of unnecessary hypertension drug therapy: QALYs vs HYE.衡量不必要的高血压药物治疗的不良反应：质量调整生命年与健康期望寿命的比较
Clin Invest Med. 1991 Jun;14(3):266-70.
8
The healthy-years equivalents: how to measure them using the standard gamble approach.健康年等效值：如何使用标准博弈法进行测量。
Med Decis Making. 1991 Apr-Jun;11(2):140-6. doi: 10.1177/0272989X9101100212.
9
A study to develop clinical decision rules for the use of radiography in acute ankle injuries.一项关于制定急性踝关节损伤中使用X线摄影的临床决策规则的研究。
Ann Emerg Med. 1992 Apr;21(4):384-90. doi: 10.1016/s0196-0644(05)82656-3.
10
A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer.一个用于对儿童癌症幸存者健康状况进行分类的综合多属性系统。
J Clin Oncol. 1992 Jun;10(6):923-8. doi: 10.1200/JCO.1992.10.6.923.
Zotero 插件